| Financial Year |
March 31 2023 |
| Monetary Funds |
71,138,940.83 |
| Held-for-trading Financial Assets |
10,000.00 |
| Notes Receivable |
6,120,000.00 |
| Accounts Receivable |
140,145,814.64 |
| Advances to Suppliers |
205,388,792.23 |
| Other Receivables |
37,255,608.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
117,912,547.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
172,018.38 |
| Other Current Assets |
36,699,807.94 |
| Total Current Assets |
637,896,553.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
12,433,214.97 |
| Investment Properties |
59,147,204.38 |
| Fixed Assetes |
310,424,725.85 |
| Under-construction Projects |
126,747,450.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
240,818,898.01 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,936,435.39 |
| Deferred Income Tax Assets |
22,482,653.67 |
| Other Non-Current Assets |
875,274,324.07 |
| Sub-Total of Non-Current Assets |
1,684,583,394.10 |
| Total Assets |
2,322,479,947.18 |
| Short-Term Loans |
29,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
108,932,978.55 |
| Accounts Received In Advance |
6,872,182.87 |
| Employee Compensation Payable |
5,806,140.02 |
| Taxes Payable |
4,922,894.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
132,429,587.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,856,242.54 |
| Other Current Liabilities |
564,472.74 |
| Sub-Total of Current Liabilities |
314,985,850.92 |
| Long-term Loans |
27,658,800.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
216,133.12 |
| Deferred Income Tax Liabilities |
240,112,555.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
272,353,551.89 |
| Total Liabilities |
587,339,402.81 |
| Paid-In Capital(Or Share Stock) |
919,994,639.00 |
| Capital Surplus |
1,718,444,492.71 |
| Surplus Reserve |
47,784,436.80 |
| LESS:Treasury Stock |
84,320,000.00 |
| Undistributed Profits |
-1,461,942,705.77 |
| Minority Stockholder's Interest |
658,367,974.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,076,772,569.44 |
| Owner's Equity（Stockholder's Equity） |
1,735,140,544.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,322,479,947.18 |
